Number of the records: 1  

A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications

  1. TitleA novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications
    Author Jusková Mária 1983- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    SCOPUS
    Co-authors Šoltésová Prnová Marta 1986- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    ORCID

    Štefek Milan 1950-2023 SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV    SCOPUS    ORCID

    Source document Pharmazie : an international journal of pharmaceutical sciences. Vol. 69, no. 10 (2014), p. 747-751
    Languageeng - English
    CountryDE - Germany
    Document kindrozpis článkov z periodík (rbx)
    CitationsALEMAN-GONZALEZ-DUHART, D. - TAMAY-CACH, F. - ALVAREZ-ALMAZAN, S. - MENDIETA-WEJEBE, J.E. Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones. In PPAR RESEARCH. ISSN 1687-4757, 2016, vol. 2016, 10 p., art. no. 7614270.
    WU, J.H. - ZHANG, D. - WANG, Y. - MAO, S.H. - XIAO, S.W. - CHEN, F. - FAN, P. - ZHONG, M.Q. - TAN, J. - YANG, J.T. Electric Assisted Salt-Responsive Bacterial Killing and Release of Polyzwitterionic Brushes in Low-Concentration Salt Solution. In LANGMUIR. ISSN 0743-7463, 2019, vol. 35, no. 25, p. 8285-8293.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2014
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1691/ph.2014.4596
    article

    article

    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    201420131.003Q30.359Q2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.